Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population

Severe Strongyloides stercoralis, such as hyperinfection syndrome, carries a high mortality risk. Even with appropriate treatment, patients may experience infectious complications and failure of therapy. Currently, there are no Food and Drug Administration–approved parenteral therapies available for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Case Rep
Main Authors: Zeitler, Kristen, Jariwala, Ripal, Restrepo-Jaramillo, Ricardo, Kapadia, Shyam, Casanas, Beata, Alrabaa, Sally, Sriaroon, Chakrapol
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5990086/
https://ncbi.nlm.nih.gov/pubmed/29866667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-223138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados